key: cord-1019075-04f3x5vg
authors: Blot, Mathieu; Jacquier, Marine; Manoha, Catherine; Piroth, Lionel; Charles, Pierre-Emmanuel
title: Alveolar SARS-CoV-2 viral load is tightly correlated with severity in COVID-19 ARDS
date: 2020-08-08
journal: Clin Infect Dis
DOI: 10.1093/cid/ciaa1172
sha: 98f2f3c98d55006f95ac28662b37ac2c7c50df24
doc_id: 1019075
cord_uid: 04f3x5vg

nan

A c c e p t e d M a n u s c r i p t

Magleby et al. recently reported the prognostic value of the baseline SARS-CoV-2 viral load as assessed by nasopharyngeal swab sampling obtained upon hospital admission (1) . In a large group of patients from two American hospitals, the authors showed that the greater the viral load, the higher the risk of requiring ventilator support. As a prognostic tool, PCR appears to be clinically relevant given the 5 to 12-day timeframe generally preceding ICU admission in patients with respiratory symptoms. These results raise several issues.

First, the host's ability to clear SARS-CoV-2 from the upper airways seems to be correlated with the risk of further respiratory distress. Accordingly, the so-called "cytokine storm" While anti-inflammatory approaches (i.e. dexamethasone) have shown promising results in the most severe cases (5), efforts still need to be made to find effective anti-viral therapies in order to combine antiviral and immune-modulator effects as parts of COVID-19 ARDS management.

Impact of SARS-CoV-2 Viral Load on Risk of Intubation and Mortality Among Hospitalized Patients with Coronavirus Disease

Dysregulation of immune response in patients with COVID-19 in Wuhan, China

Immune modulation in COVID-19: Strategic considerations for personalized therapeutic intervention

Dexamethasone in Hospitalized Patients with Covid-19 -Preliminary Report

A c c e p t e d M a n u s c r i p t A c c e p t e d M a n u s c r i p t